The Effect of Neurofeedback-assisted Mindfulness Training in Employees With Emotional Labor
9 janvier 2019 mis à jour par: Seoul National University Hospital
The Effect of Neurofeedback-assisted Mindfulness Training on Stress Reduction in Employees With Emotional Labor
The purpose of this study is to verify the effect of neurofeedback-assisted mindfulness training for workers.
Subjects who can participate in the screening are assigned to one neurofeedback-assisted mindfulness training group, mindfulness only training group, and self-treatment group.
The neurofeedback-assisted mindfulness group and the mindfulness group meet with psychologist and have education for the mindfulness training with or without neurofeedback respectively, a total of 4 times, once a week.
On the other hand, the self-treatment group provides self-education by providing the stress education kit.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
After screening, Pre-evaluation is conducted on the subjects who agreed to participate in the study.
Pre-assessment includes questionnaires related to stress, emotional labor, resilience, sleep, etc., and includes stress-related physiological measures using HRV, 2 lead EEG.
After the pre-evaluation, the neurofeedback-assisted mindfulness and mindfulness training group will have education sessions with a psychologist for 30 minutes at a time, once a week, for a total of 4 sessions (one month for a period).
The education includes the instruction of the application including mindfulness training, with or without neurofeedback, and the review for the accomplishment of the training.
Participants should follow the instruction and the training schedule which is arranged in advance.
On the other hand, for a self-care control, the education sessions are not provided and self-learning materials are provided once a week.
The purpose of the study is to find the effectiveness of mindfulness training on reduction of stress and severity of emotional labor.
Especially, mindfulness training group with neurofeedback might be expected to show the highest improvement in various clinical scales and biomarkers including EEG and HRV.
Type d'étude
Interventionnel
Inscription (Réel)
96
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Gyeonggi-do
-
Seongnam, Gyeonggi-do, Corée, République de, 13605
- Seoul National University Bundang Hospital
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
19 ans à 65 ans (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Oui
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- Workers over the age of 19 and under 65
- In the Perceived Stress Scale 14 points or more
- If you are currently taking medication due to psychiatric illnesses such as depression, anxiety disorder, insomnia, etc., the dose must be stabilized for last 6 months, is expected to have no change in drug dose during the clinical trial
- If you understand the protocol and voluntarily agree to participate
- If you have an Android phone
Exclusion Criteria:
- Age under 19, adult over 65
- If you have dementia, intellectual disability, or other cognitive impairment
- If you have convulsive disorder, stroke, or other neurological disorder
- If you have psychosis such as schizophrenia or bipolar disorder or you have a history
- If you have a disease that can affect the reliability of HRV test, such as heart disease or lung disease.
- Has received non-pharmacological psychiatric or counseling treatment within the current or last 6 months.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Mindfulness training with neurofeedback
mindfulness training with neurofeedback using mobile application instruction and review of the application will be provided
|
mindfulness training using mobile application
|
|
Comparateur actif: Mindfulness training
mindfulness training using mobile application instruction and review of the application will be provided
|
mindfulness training using mobile application
|
|
Aucune intervention: Self-care
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change from baseline Perceived Stress Scale (PSS) score at 4, 8 weeks
Délai: Baseline and after 4, 8 weeks later
|
The full name: Perceived Stress Scale - 10 item form 14-item scale developed by Cohen et al. (1983) that emphasizes subjective perception of stress.
Measures the degree of perceived unforeseeable, uncontrollable, and overwhelming experience of stress in the past month.
Although the 14-item PSS tend to exhibit good reliability, four of the items tend to perform poorly when evaluated using exploratory factor analysis (Cohen et al., 1988).
As a result, the PSS is commonly implemented using the 10-item form.
The questions are rated on 5-point Likert scale; 0 (never), 1 (almost never), 2 (sometimes), 3 (fairly often), 4 (very often).
Higher scores represent worse outcomes.
The scores of each scale sum into the total score.
Thus the total score ranges from 0 to 40.
|
Baseline and after 4, 8 weeks later
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change from baseline Korean Emotional Labor Assessment Tool score
Délai: Baseline and after 4, 8 weeks later
|
The total of 26 items were Emotional expression and control 5 items, organizational monitoring and management system 4 items, forced customer response 4 items, emotional damage 6 items, organizational protection system 7 items, and organizational protection system is reverse coding and summed up. 4 point Likert scale (1 = not at all, 5 = very much), and the possible total score ranges from 26 to 130 points.
The higher the score, the more emotional labor means.
|
Baseline and after 4, 8 weeks later
|
|
Change from baseline Korean abbreviation of Occupational Stress Scale (KOSS) score
Délai: Baseline and after 4, 8 weeks later
|
total of 24 items were used, and each item was not at all (from 1 point) to very much (5 points).
The higher the score, the more the job stress means.
Job demand, Insufficient job control, job insecurity, interpersonal conflict, Organizational system, Lack of reward and Occupational climate.
|
Baseline and after 4, 8 weeks later
|
|
Change from baseline Patient Health Questionnaire 9 (PHQ-9) score
Délai: Baseline and after 4, 8 weeks later
|
The total score is 0 to 27, and the higher the total score, the more severe the depressive symptoms.
Cutpoints of 5, 10, 15 and 20 represent the thresholds for mild, moderate, moderate severe, and severe depression, respectively.
|
Baseline and after 4, 8 weeks later
|
|
Change from baseline Brief resilience scale (BRS) score
Délai: Baseline and after 4, 8 weeks later
|
It is composed of 6 questions and is evaluated on the 5-point scale (1: not at all, 5: very much)
|
Baseline and after 4, 8 weeks later
|
|
Change from baseline Athens Insomnia Scale (AIS) score
Délai: Baseline and after 4, 8 weeks later
|
total score of 6 points was used as a breakpoint, this Using the quality index of Pittsburgh Sleep, which is widely used to evaluate the quality of sleep
|
Baseline and after 4, 8 weeks later
|
|
Korean Mindful Attention Awareness Scale; K-MAAS
Délai: Baseline and after 4, 8 weeks later
|
Modified from the Mindful Attention Awareness Scale, developed by Brown and Ryan (2003).
15-item scale designed to assess a core characteristic of dispositional mindfulness, namely, open or receptive awareness of and attention to what is taking place in the present.
|
Baseline and after 4, 8 weeks later
|
|
Stroop test
Délai: Baseline and after 4, 8 weeks later
|
assess the ability to inhibit cognitive interference that occurs when the processing of a specific stimulus feature impedes the simultaneous processing of a second stimulus attribute
|
Baseline and after 4, 8 weeks later
|
|
Heart Rate Variability (HRV)
Délai: Baseline and after 4, 8 weeks later
|
HRV is recorded with a device (neuroNicle FX2, Laxtha) which include EEG and HRV recording system.
HRV is calculated from pulse rate signal recorded at earlobe.
|
Baseline and after 4, 8 weeks later
|
|
Quantitative electroencephalography (QEEG)
Délai: Baseline and after 4, 8 weeks later
|
EEG is recorded with a device (neuroNicle FX2, Laxtha) which include EEG and HRV recording system. EEG signal is acquired at the prefrontal area, two channels (FP1, FP2) on forehead. Power spectrum analysis of the EEG data will be performed using Fourier analysis. And absolute power, relative power, of each frequency band, symmetry are included. |
Baseline and after 4, 8 weeks later
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Jeong Hyun Kim, MD, Ph.D, Seoul National Univerysity Bundang Hospital
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
7 août 2018
Achèvement primaire (Réel)
31 décembre 2018
Achèvement de l'étude (Réel)
31 décembre 2018
Dates d'inscription aux études
Première soumission
23 décembre 2018
Première soumission répondant aux critères de contrôle qualité
23 décembre 2018
Première publication (Réel)
26 décembre 2018
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
11 janvier 2019
Dernière mise à jour soumise répondant aux critères de contrôle qualité
9 janvier 2019
Dernière vérification
1 décembre 2018
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- B-1807/483-303
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .